Tag Archives: Neurological Disease

Deep Brain Stimulation for Improving Symptoms in Alzheimer’s Disease (BBC News)

Posted on January 30, 2018 by Dementia and Elderly Care News

Summary A brief BBC News item explores the potential of deep brain stimulation (DBS) therapy for improving wellbeing and cognitive function in patients with Alzheimer’s Disease and other forms of dementia. “Although we are not talking about treating the Alzheimer’s … Continue reading →

Posted in BBC News, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Alzheimer's Disease, Andres Lozano (Neurosurgeon), Brain Imaging, Canada, Deep Brain Stimulation, Deep Brain Stimulation (DBS), Deep Brain Stimulation for the Treatment of Alzheimer Disease, Deep Brain Stimulation for the Treatment of Dementia, Deep Brain Stimulation of Nucleus Basalis of Meynert (NBM DBS), Dr Carol Routledge: Alzheimer's Research UK, LaVonne Moore, Neurodegeneration, Neurodegenerative Diseases, Neurological Disease, Nucleus Basalis of Meynert, Nucleus Basalis of Meynert (NBM), Ohio State University Wexner Medical Center, Parkinson’s Dementia, Parkinson’s Disease Dementia, Treatment of Alzheimer's Disease, United States, USA, Wexner Medical Center: Ohio State University | Leave a comment

A Further Set-Back for Progress in Dementia Drug Development? (BBC News)

Posted on January 11, 2018 by Dementia and Elderly Care News

Summary Drug company Pfizer is to cease activity in its neuroscience drug discovery programmes, which will impact on ongoing research into drugs for Alzheimer’s Disease and Parkinson’s Disease. Paradoxically the company does promise plans to create a new fund dedicated … Continue reading →

Posted in BBC News, For Researchers (mostly), In the News, International, Management of Condition, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Big Pharma, Dementia Research, Dementia Research Funding, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Discovery Programmes, Drug Identification, Drug Trials Failure Rate, Drug-Development Pipeline, Global Context, Global Outlook, International Organisations, International Programmes, Neurological Conditions, Neurological Disease, Neurological Disorders, Neuroscience Drug Discovery Programmes (Pfizer), Neuroscience Research, Pfizer, Pfizer Inc., Pharmaceutical Industry, Research and Development, Research and Innovation, Research Commitment, Research Funding | Leave a comment

Parkinson’s Disease in Adults: Updated Guidance (NICE / BBC News / NHS Choices / Lancet)

Posted on August 4, 2017 by Dementia and Elderly Care News

Summary The National Institute for Health and Care Excellence recently released an updated guideline on the diagnosis and management of Parkinson’s Disease in patients aged over 18 years. This guidance updates and replaces their earlier “NG35 – Parkinson’s disease in … Continue reading →

Posted in BBC News, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, International, Management of Condition, National, NHS Digital (Previously NHS Choices), NICE Guidelines, Non-Pharmacological Treatments, Parkinson's Disease, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, UK | Tagged : National Institute on Aging (USA), Amantadine, BBC Health News, Behind the Headlines, Biomedical Research Centres (NIHR), Comprehensive Clinical Trials Unit: University College London, COMT Inhibitors, Deep Brain Stimulation (DBS), Diagnosing Parkinson's Disease, Dopamine Agonists, Dr Brian Fiske: The Michael J Fox Foundation for Parkinson's Research, Exenatide, Exenatide as Potential Treatment for Patients with Parkinson's Disease, GLP-1 Agonists for Parkinson's Disease, Impulse Control Disorders, Impulse Control Disorders (ICDs), Impulsive-Compulsive Disorders, Impulsivity, Information and Support, Institute of Nuclear Medicine: University College London Hospitals NHS Trust, Intramural Research Program: National Institute on Aging, Leonard Wolfson Experimental Neuroscience Centre, Levodopa, Levodopa–Carbidopa Intestinal Gel, MAO‑B Inhibitors, Michael J Fox Foundation, Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS), National Hospital for Neurology and Neurosurgery, National Hospital for Neurology and Neurosurgery: UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery: University College London Hospitals NHS Foundation Trust, National Institute for Health and Care Excellence (NICE), National Institute for Health Research Biomedical Research Centres, National Institute for Health Research UCL Hospitals Biomedical Research Centre, National Institutes of Health (Baltimore), Neurological Disease, Neurological Disorders, NHNN: National Hospital for Neurology and Neurosurgery, NIHR Biomedical Research Centres, Non-Pharmacological Management of Symptoms, Occupational Therapy, Off-Label Drug Repurposing Trials, Palliative Care, Parkinson's, Parkinson's Disease in Over 20s (Updated and Replaced), Parkinson’s Disease, Parkinson’s Disease Diagnosis, Parkinson’s Disease In Adults: NICE Guidance (NG71), Parkinson’s Disease in Adults: Updated Guidance (NICE 2017), Parkinson’s Pathway, Parkinsonian Symptoms, Pharmacological Management of Motor Symptoms, Pharmacological Management of Non-Motor Symptoms, Potential Repurposing of Drugs to Slow Progression of Parkinson’s Disease, Professor David Dexter: Parkinson's UK, Repurposing GLP-1 Agonists, Repurposing of Drugs, Sobell Department of Motor Neuroscience (UCL), Speech and Language Therapy (SALT), Translational Gerontology Branch: National Institute on Aging, Type 2 Diabetes Drug: Exenatide, University College London (UCL), University College London Hospitals NHS Trust, University College London Institute of Neurology, University College London Institute of Neurology and the National Hospital for Neurology and Neurosurgery, US National Institute of Aging | Leave a comment

Perioperative Care of Patients With Neurological Conditions (Health Service Insights)

Posted on June 30, 2017 by Dementia and Elderly Care News

Summary A US review covers the peri-operative care of patients with neurological conditions. It examines, in particular, aspects of the preoperative, intraoperative, and postoperative care for persons with conditions including delirium, stroke, epilepsy, myasthenia gravis, and Parkinson Disease. Full Text … Continue reading →

Posted in Acute Hospitals, Delirium, Diagnosis, For Nurses and Therapists (mostly), International, Management of Condition, Non-Pharmacological Treatments, Parkinson's Disease, Person-Centred Care, Pharmacological Treatments, Quick Insights, Stroke | Tagged Bronx-Lebanon Hospital Center (New York), Carotid Artery Disease and Stroke During Coronary Artery Bypass, Contraindications for Thrombolytic Therapy, Department of Medicine: Bronx-Lebanon Hospital Center, Department of Medicine: Icahn School of Medicine at Mount Sinai, Epilepsy, Health Service Insights (Journal), Icahn School of Medicine at Mount Sinai (New York), Intraoperative Care, Medications Which May Worsen Myasthenia Gravis, Myasthenia Gravis, Neurological Conditions, Neurological Disease, Neurological Disorders, Peri-Operative Care of the Elderly, Perioperative Care, Perioperative Care of Patients With Neurological Conditions, Perioperative Stroke, Postoperative Care, Preoperative Care, USA | Leave a comment

Progression of Neurological Diseases Presaged By Hidden Alterations in Artistic Style? (BBC News / Neuropsychology)

Posted on December 29, 2016 by Dementia and Elderly Care News

Summary Psychological researchers performed detailed mathematical analysis (“fractal analysis”) of barely perceptible changes to the brushstrokes used by artists, some of whom later developed neurological diseases. Analysis of hidden patterns of change in the fractal dimension of paintings reveals that … Continue reading →

Posted in BBC News, For Researchers (mostly), In the News, International, Quick Insights, UK, Universal Interest | Tagged Alterations to Artistic Style, and Wear Valleys NHS Trust, Artworks, BBC Health News, Department of Computer Science: Maynooth University, Department of Psychology: University of Liverpool, Disease Progression, Fine Art, Fine Motor Control, Fractal Analysis of Artistic Brushstrokes, Fractal Analysis of Neurological Changes (In Artists), Fractal Analysis of Paintings, Ireland, Maynooth University, Neurological Conditions, Neurological Disease, Neurological Disorders, Neuropsychology (Journal), Progression of Neurological Diseases, Pyschology of Art, Symptoms and Progression of Dementia, Tees Esk, University of Liverpool, Variations in Motor Control | Leave a comment

Fourth Annual Deep Brain Stimulation (DBS) Think Tank (Frontiers in Integrative Neuroscience / International Journal of Neuroscience)

Posted on December 15, 2016 by Dementia and Elderly Care News

Summary An annual round-up of developments in the field of Deep Brain Stimulation (DBS). (x3). Full Text Link Reference Deeb, W. Giordano, JJ. [and] Rossi, PJ. [et al] (2016). Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: a … Continue reading →

Early Indications Suggest Zika Virus Might Damage Adult Brains Resulting in Long-Term Neurological Conditions (NHS Choices / Cell Stem Cell)

Posted on August 20, 2016 by Dementia and Elderly Care News

Summary The Zika virus has been linked with microcephaly in human babies, and has also – more tentatively – been linked to Guillain-Barre Syndrome (GBS), but until now was not thought likely to affect the adult population beyond minor short-term … Continue reading →

Posted in Animal Studies, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged Aging and Stem Cell Regeneration: Sanford Burnham Prebys Discovery Institute, Apoptosis and Reduced Cellular Proliferation, Apoptotic Neural Cell Death, Behind the Headlines, California Institute of Regenerative Medicine, Caribbean Countries, Cell Stem Cell (Journal), Central America, Central Nervous System Abnormalities, CNS Infections, Del. E. Webb Center for Neuroscience: Sanford Burnham Prebys Discovery Institute, Dementia Risk Factors, Dengue Virus, Department of Neurosciences: University of California, Division of Inflammation Biology: La Jolla Institute for Allergy and Immunology, Environmental Risk Factors, Flaviviruses, Genetically Engineered Mice, Guillain-Barré Syndrome, Guillain-Barre Syndrome (GBS), Hippocampus, Hippocampus-Based Cognitive Processes, Howard Hughes Medical Institute, Howard Hughes Medical Institute: Rockefeller University, Infection, Infection and Infectious Diseases, La Jolla Institute for Allergy and Immunology, La Jolla Institute for Genomic Medicine, Laboratory for Pediatric Brain Diseases: Howard Hughes Medical Institute, Long Term Neurological Conditions, Microcephaly, National Institutes of Health (NIH), National Institutes of Health (US), Neural Progenitor Cells (NPCs), Neurobiology of ZIKV and Potential Neuropsychiatric Manifestations, Neurogenesis, Neurological Complications, Neurological Conditions, Neurological Disease, Neurological Disorders, Pathogenesis, Rady Children’s Institute for Genomic Medicine: University of California, Risk Factors, Risks to Immunocompromised Adults, Rockefeller University, Sanford Burnham Prebys Discovery Institute, Simons Foundation of Autism Research Initiative, South America, Subgranular Zone (SGZ) of Hippocampus, Subventricular Zone (SVZ) of Anterior Forebrain, Systemic ZIKV Can Infect Neural Progenitor Cells in the Adult Brain, The Americas, TKO Mice (Mice With Immune Cells Knocked Out), United States, University of California, USA, World Health Organization (WHO): Zika Public Health Emergency of International Concern, Zika Fever, Zika Infection Leading to Neural Cell Death and Reduced Cell Division, Zika Virus, Zika Virus (ZIKV) Infection, Zika Virus Epidemiology and Recent Epidemics, Zika Virus Infection: Public Health Issues, Zika Virus Outbreaks in the Americas, ZIKV Pandemic | Leave a comment

Tag Archives: Neurological Disease

Deep Brain Stimulation for Improving Symptoms in Alzheimer’s Disease (BBC News)

A Further Set-Back for Progress in Dementia Drug Development? (BBC News)

Parkinson’s Disease in Adults: Updated Guidance (NICE / BBC News / NHS Choices / Lancet)

Perioperative Care of Patients With Neurological Conditions (Health Service Insights)

Progression of Neurological Diseases Presaged By Hidden Alterations in Artistic Style? (BBC News / Neuropsychology)

Fourth Annual Deep Brain Stimulation (DBS) Think Tank (Frontiers in Integrative Neuroscience / International Journal of Neuroscience)

Early Indications Suggest Zika Virus Might Damage Adult Brains Resulting in Long-Term Neurological Conditions (NHS Choices / Cell Stem Cell)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites